Delivery Order SPE2DR25D2014-SPE2DR26FA3Q2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (via its parent company Cencora, Inc.) on January 9, 2026, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $11,167.12 and an ultimate completion date of January 12, 2026. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The pharmaceutical distributor will perform this work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,594.48 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with an ultimate completion date of January 13, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company, Cencora, Inc.'s, larger...
- The Defense Logistics Agency awarded a $3,081.23 delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This firm fixed-price contract, with a completion date of January 20, 2026, was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $2,264.83 and an ultimate completion date of January 15, 2026. This non-set-aside contract was competitively awarded and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.999 billion through December 2026),...
- The Defense Logistics Agency awarded a $4,657.97 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs on January 23, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price contract, which carries no set-aside designation, will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,797.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector (two-pack) on January 15, 2026, with completion scheduled for January 16, 2026. This non-set-aside contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a leading pharmaceutical distributor serving federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,094.04 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract is a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $1,209.24 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector packs (2-count). This competitively awarded, non-set-aside delivery order was issued on June 17, 2025, with an ultimate completion date of June 18, 2025, and operates under firm fixed pricing. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office...
- The Defense Logistics Agency awarded a $1,775.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector 2-packs on December 16, 2025, with completion due by December 17, 2025. This non-set-aside contract is a child order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The company, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $1,023.31 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Epinephrine 0.15 mg auto-injector 2-packs. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 13, 2026, with performance at the contractor's Conshohocken, Pennsylvania facility. The contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA3Q2Delivery Order
The Defense Logistics Agency awarded a $1,797.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector two-packs, with an ultimate completion date of January 27, 2026. This is a non-set-aside, competitively awarded contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, through its parent Cencora, Inc., is a major pharmaceutical distributor providing critical medical supplies to the Department of Defense and other federal healthcare systems. The IDC vehicle enables the company to supply an extensive range of pharmaceutical products and medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This particular delivery order represents a small-value transaction within the broader pharmaceutical prime vendor framework, supporting the Defense Health Agency and other government healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 1/25/26 |